Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 71, 2011 - Issue 8
Submit an article Journal homepage
291
Views
8
CrossRef citations to date
0
Altmetric
Research Article

High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy

Gustav ÖstnerDepartment of Clinical Chemistry, Lund University Hospital, Lund, Sweden
,
Veronica LindströmDepartment of Clinical Chemistry, Lund University Hospital, Lund, Sweden
,
Alexander B. Postnikov HyTest Ltd, Turku, Finland
,
Tatiana I. Solovyeva HyTest Ltd, Turku, Finland
,
Össur I. EmilssonDepartment of Clinical Chemistry, Lund University Hospital, Lund, Sweden
&
Anders GrubbDepartment of Clinical Chemistry, Lund University Hospital, Lund, SwedenCorrespondence[email protected]
Pages 676-682 | Received 03 May 2011, Accepted 17 Aug 2011, Published online: 21 Oct 2011

References

  • Grubb AO. Cystatin C–properties and use as diagnostic marker. Adv Clin Chem 2000;35:63–99.
  • Olafsson I, Grubb A. Hereditary cystatin C amyloid angiopathy. Amyloid 2000;7:70–9.
  • Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A, Jensson O. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988;2:603–4.
  • Abrahamson M, Jonsdottir S, Olafsson I, Jensson O, Grubb A. Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 1992;89:377–80.
  • Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001;8:316–20.
  • Wahlbom M, Wang X, Lindström V, Carlemalm E, Jaskolski M, Grubb A. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J Biol Chem 2007;282:18318–26.
  • Abrahamson M, Grubb A. Increased body temperature accelerates aggregation of the Leu-68 → Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc Natl Acad Sci USA 1994;91:1416–20.
  • Bjarnadottir M, Nilsson C, Lindström V, Westman A, Davidsson P, Thormodsson F, Bløndal H, Gudmundsson G, Grubb A. The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid 2001;8:1–10.
  • Nilsson M, Wang X, Rodziewicz-Motowidlo S, Janowski R, Lindström V, Önnerfjord P, . Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J Biol Chem 2004;279:24236–45.
  • Olafsson I, Löfberg H, Abrahamson M, Grubb A. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand J Clin Lab Invest 1988;48:573–82.
  • Abrahamson M, Dalbøge H, Olafsson I, Carlsen S, Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett 1988;236:14–8.
  • Lindahl P, Abrahamson M, Björk I. Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. Biochem J 1992;281:49–55.
  • Jeppson JO, Laurell CB, Franzen B. Agarose gel electrophoresis. Clin Chem 1979;25:629–38.
  • Rasband WS. ImageJ. 1.42 ed. Bethesda, Maryland, USA: U. S. National Institutes of Health; 1997–2011. http://imagej.nih.gov/ij/.
  • Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010;10:345–52.
  • Giorgetti S, Raimondi S, Pagano K, Relini A, Bucciantini M, Corazza A, . Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils. J Biol Chem 2011;286:2121–31.
  • Cardoso I, Merlini G, Saraiva MJ. 4′-iodo-4′-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters. FASEB J 2003;17:803–9.
  • Tagliavini F, Forloni G, Colombo L, Rossi G, Girola L, Canciani B, . Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol 2000;300:1309–22.
  • Aitken JF, Loomes KM, Konarkowska B, Cooper GJ. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. Biochem J 2003;374:779–84.
  • Ono K, Yamada M. Antioxidant compounds have potent anti fibrillogenic and fibril destabilizing effects for synuclein fibrils in vitro. J Neurochem 2006;97:105–15.
  • Forloni G, Colombo L, Girola L, Tagliavini F, Salmona M. Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett 2001;487:404–7.
  • Aitken JF, Loomes KM, Scott DW, Reddy S, Phillips AR, Prijic G, . Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice. Diabetes 2010;59:161–71.
  • Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, . Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002;416:507–11.
  • Rochet JC. Novel therapeutic strategies for the treatment of protein-misfolding diseases. Expert Rev Mol Med 2007;9: 1–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.